Sinopharm Group Co Ltd
F:X2S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sinopharm Group Co Ltd
F:X2S
|
CN |
|
M
|
Marsh & McLennan Companies Inc
F:MSN
|
US |
|
I
|
Itochu Corp
F:IOC
|
JP |
|
Honda Motor Co Ltd
F:HDM
|
JP |
|
S
|
Spotify Technology SA
F:639
|
LU |
|
ING Groep NV
LSE:0A2K
|
NL |
Wall St Price Targets
X2S Price Targets Summary
Sinopharm Group Co Ltd
According to Wall Street analysts, the average 1-year price target for X2S is 2.687 EUR with a low forecast of 2.165 EUR and a high forecast of 3.281 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is X2S's stock price target?
Price Target
2.687
EUR
According to Wall Street analysts, the average 1-year price target for X2S is 2.687 EUR with a low forecast of 2.165 EUR and a high forecast of 3.281 EUR.
What is the Revenue forecast for Sinopharm Group Co Ltd?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
26%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 26%.
What is the Net Income forecast for Sinopharm Group Co Ltd?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 10%.
